palbociclib
pfizer
['1069', 'breast', 'pfizer']
an analysis of a phase 3 study examining the relationship between overall survival &amp; tumor growth rates in pts w/ advanced #breastcancer who received a cdk4/6 inhibitor + endocrine therapy vs placebo + endocrine therapy is being presented at #asco22 1069 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ